| Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview S Mondal, N Adhikari, S Banerjee, SA Amin, T Jha European journal of medicinal chemistry 194, 112260, 2020 | 371 | 2020 |
| Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors SA Amin, S Banerjee, K Ghosh, S Gayen, T Jha Bioorganic & medicinal chemistry 29, 115860, 2021 | 164 | 2021 |
| HDAC6 as privileged target in drug discovery: A perspective S Pulya, SA Amin, N Adhikari, S Biswas, T Jha, B Ghosh Pharmacological research 163, 105274, 2021 | 138 | 2021 |
| Design of aminopeptidase N inhibitors as anti-cancer agents SA Amin, N Adhikari, T Jha Journal of Medicinal Chemistry 61 (15), 6468-6490, 2018 | 99 | 2018 |
| Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some in-house molecules … SA Amin, K Ghosh, S Gayen, T Jha Journal of Biomolecular Structure and Dynamics 39 (13), 4764-4773, 2021 | 97 | 2021 |
| Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview S Banerjee, N Adhikari, SA Amin, T Jha European Journal of Medicinal Chemistry 164, 214-240, 2019 | 88 | 2019 |
| Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review R Sarkar, S Banerjee, SA Amin, N Adhikari, T Jha European journal of medicinal chemistry 192, 112171, 2020 | 86 | 2020 |
| Fight against novel coronavirus: a perspective of medicinal chemists SA Amin, T Jha European Journal of Medicinal Chemistry 201, 112559, 2020 | 72 | 2020 |
| Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview N Adhikari, A Mukherjee, A Saha, T Jha European Journal of Medicinal Chemistry 129, 72-109, 2017 | 68 | 2017 |
| Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease … K Ghosh, SA Amin, S Gayen, T Jha Journal of Molecular Structure 1224, 129026, 2021 | 67 | 2021 |
| QSAR study on some pyridoacridine ascididemin analogues as anti-tumor agents B Debnath, S Gayen, S Bhattacharya, S Samanta, T Jha Bioorganic & medicinal chemistry 11 (24), 5493-5499, 2003 | 66 | 2003 |
| Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study N Adhikari, SA Amin, A Saha, T Jha European Journal of Medicinal Chemistry 137, 365-438, 2017 | 65 | 2017 |
| Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies? SA Amin, N Adhikari, T Jha Pharmacological Research 122, 8-19, 2017 | 64 | 2017 |
| Synthesis, screening and quantitative structure–activity relationship (QSAR) studies of some glutamine analogues for possible anticancer activity K Srikanth, CA Kumar, B Ghosh, T Jha Bioorganic & medicinal chemistry 10 (7), 2119-2131, 2002 | 64 | 2002 |
| Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies S Das, SA Amin, T Jha European journal of medicinal chemistry 223, 113623, 2021 | 62 | 2021 |
| Exploring pyrazolo[3,4-d]pyrimidine phosphodiesterase 1 (PDE1) inhibitors: a predictive approach combining comparative validated multiple molecular modelling … SA Amin, S Bhargava, N Adhikari, S Gayen, T Jha Journal of Biomolecular Structure and Dynamics 36 (3), 590-608, 2018 | 58 | 2018 |
| QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters S Gayen, B Debnath, S Samanta, T Jha Bioorganic & medicinal chemistry 12 (6), 1493-1503, 2004 | 57 | 2004 |
| 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological activity and QSAR study S Samanta, K Srikanth, S Banerjee, B Debnath, S Gayen, T Jha Bioorganic & medicinal chemistry 12 (6), 1413-1423, 2004 | 57 | 2004 |
| HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches N Adhikari, SA Amin, P Trivedi, T Jha, B Ghosh European journal of medicinal chemistry 157, 1127-1142, 2018 | 55 | 2018 |
| Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead … N Adhikari, AK Halder, S Mallick, A Saha, KD Saha, T Jha Bioorganic & Medicinal Chemistry 24 (18), 4291-4309, 2016 | 53 | 2016 |
